Nuclear transport of wilms′ tumour protein Wt1 involves importins α and β

Cellular Physiology and Biochemistry

Volumn 29, Issue 1-2, 2012, Pages 223-232

  Depping, Reinhard ^a   Schindler, Susann G ^a   Jacobi, Charlotte ^b   Kirschner, Karin M ^b   Scholz, Holger ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Importin; Nuclear localisation signal; Nuclear transport; Transcription factor; Wilms tumour protein

Indexed keywords

KARYOPHERIN ALPHA; KARYOPHERIN BETA; WT1 PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SITE DIRECTED MUTAGENESIS; ZINC FINGER MOTIF;

EID: 84859848486     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000337603     Document Type: Article

References (65)

1. Huff V, Miwa H, Haber DA, Call KM, Housman D, Strong LC, Saunders GF: Evidence for WT1 as a Wilms tumor (WT) gene: Intragenic germinal deletion in bilateral WT. Am J Hum Genet 1991;48:997-1003. (Pubitemid 21891645)
2. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman DE: Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67:437-447. (Pubitemid 121001458)
3. Park S, Bernard A, Bove KE, Sens DA, Hazen-Martin DJ, Garvin AJ, Haber DA: Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nature Genet 1993;5:363-367. (Pubitemid 23351307)
4. Hastie ND: The genetics of Wilms tumor -a case of disrupted development. Annu Rev Genet 1994;28:523-558.
5. Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, Yao M, Takahashi E, Nakano Y, Hirabayashi H, Shintani Y, Oka Y, Tsuboi A, Hosen N, Asada M, Fujioka T, Murakami M, Kanato K, Motomura M, Kim EH, Kawakami M, Ikegame K, Ogawa H, Aozasa K, Kawase I, Sugiyama H: Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 2002;100:297-303. (Pubitemid 34728987)
6. Koesters R, Linnebacher M, Coy JF, Germann A, Schwitalle Y, Findeisen P, von Knebel Doeberitz M: WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells. Int J Cancer 2004;109:385-392. (Pubitemid 38252767)
7. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S: Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumorspecific promoter methylation. Cancer Res 2001;61:921-925. (Pubitemid 32174404)
8. Miwa H, Beran M, Saunders GF: Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 1992;6:405-409.
9. Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I: Expression of the candidate Wilms' tumor gene, WT1, in human leukemia cells. Leukemia 1993;7:970-977. (Pubitemid 23230975)
10. Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E: Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 1995;9:1060-1067.
11. Yang L, Han Y, Suarez Saiz F, Minden MD: A tumor suppressor and oncogene: the WT1 story. Leukemia 2007;21:868-876. (Pubitemid 46672061)
12. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 1993;74:679-691. (Pubitemid 23259748)
13. Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A: YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 1999;126:1845-1857. (Pubitemid 29240319)
14. Herzer U, Crocoll A, Barton D, Howells N, Englert C: The Wilms tumor suppressor gene Wt1 is required for development of the spleen. Curr Biol 1999;9:837-840. (Pubitemid 29375188)
15. Wagner N, Wagner KD, Theres H, Englert C, Schedl A, Scholz, H: Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. Genes Dev 2005;19:2631-2642. (Pubitemid 41565982)
16. Wagner KD, Wagner, N, Vidal VP, Schley G, Wilhelm D, Schedl A, Englert C, Scholz H: The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J 2002;21:1398-1405. (Pubitemid 34246518)
17. Martinez-Estrada OM, Lettice LA, Essafi A, Guadix JA, Slight J, Velecela V, Hall E, Reichmann J, Devenney PS, Hohenstein P, Hosen N, Hill RE, Muñoz-Chápuli R, Hastie ND: Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nature Genet 2010;42:89-93.
18. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990;60:509-520.
19. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP: Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343:774-778.
20. Herzer U, Lutz B, Hartmann K, Englert C: The speckling domain of the Wilms tumor suppressor WT1 overlaps with the transcriptional repression domain. FEBS Lett 2001;494:69-73. (Pubitemid 32289374)
21. Kennedy D, Ramsdale T, Mattick J, Little M: An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modeling. Nat Genet 1996;12:329-331.
22. Scharnhorst V, van der Eb AJ, Jochemsen AG: WT1 proteins: functions in growth and differentiation. Gene 2001;273:141-161. (Pubitemid 32786908)
23. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE: Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 1991;88:9618-9622. (Pubitemid 21915682)
24. Gessler M, König A, Bruns GA: The genomic organization and expression of the WT1 gene. Genomics 1992;12:807-813.
25. Laity JH, Dyson HJ, Wright, PE: Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein. Proc Natl Acad Sci USA 2000;97:11932-11935.
26. Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, van Heyningen V, Hastie ND: Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 1995;81:391-401.
27. Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G, Todorov I, Ward A: RNA binding by the Wilms tumor suppressor zinc finger protein. Proc Natl Acad Sci USA 1996;93:7562-7566. (Pubitemid 26277075)
28. Niksic M, Slight J, Sanford JR, Caceres JF, Hastie ND: The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 2004;13:463-471. (Pubitemid 38239797)
29. Bor YC, Swartz J, Morrison A, Rekosh D, Ladomery M, Hammarskjöld ML: The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron. Genes Dev 2006;20:1597-1608. (Pubitemid 43901099)
30. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJ 3rd: Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 1991;253:1550-1553. (Pubitemid 21917311)
31. Roberts SG: Transcriptional regulation by WT1 in development. Curr Opin Genet Dev 2005;15:542-547. (Pubitemid 41262411)
32. Hamilton TB, Barilla KC, Romaniuk PJ: High affinity binding sites for the Wilms' tumour suppressor protein WT1. Nucleic Acids Res 1995;23:277-284.
33. Nakagama H, Heinrich G, Pelletier J, Housman DE: Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol 1995;15:1489-1498.
34. Vajjhala PR, Macmillan E, Gonda T, Little M: The Wilms' tumour suppressor protein, WT1, undergoes CRM1-independent nucleocytoplasmic shuttling. FEBS Lett 2003;554:143-148. (Pubitemid 37324829)
35. Fried H, Kutay U: Nucleocytoplasmic transport: taking an inventory. Cell Mol Life Sci 2003;60:1659-1688. (Pubitemid 37041364)
36. Dingwall C, Laskey RA: Nuclear targeting sequences -a consensus? Trends Biochem Sci 1991;16:478-481.
37. Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, Corbett AH: Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem 2007;282:5101-5105. (Pubitemid 47093710)
38. Pemberton LF, Paschal BM: Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 2005;6:187-198. (Pubitemid 40298153)
39. Conti E, Mueller CW, Stewart M: Karyopherin flexibility in nucleocytoplasmic transport. Curr Opin Struct Biol 2006;16:237-244.
40. Xu D, Farmer A, Chook YM: Recognition of nuclear targeting signals by karyopherin-β proteins. Curr Opin Struct Biol. 2010;20:782-790.
41. Fornerod M, Ohno M, Yoshida M, Mattaj IW: CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997;90:1051-1060. (Pubitemid 27408519)
42. Ossareh-Nazari B, Gwizdek C, Dargemont C: Protein export from the nucleus. Traffic 2001;2:684-689. (Pubitemid 32904365)
43. Kahle J, Piaia E, Neimanis S, Meisterernst M, Doenecke D: Regulation of nuclear import and export of negative cofactor 2. J Biol Chem 2009;284:9382-9393.
44. Kirschner KM, Wagner N, Wagner KD, Wellmann S, Scholz H: The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the alpha4integrin gene. J Biol Chem 2006;281:31930-31939. (Pubitemid 46041455)
45. Kirschner KM, Sciesielski LK, Scholz H: Wilms' tumour protein Wt1 stimulates transcription of the gene encoding vascular endothelial cadherin. Pflugers Arch Eur J Physiol 2010;460:1051-1061.
46. Depping R, Steinhoff A, Schindler SG, Friedrich B, Fagerlund R, Metzen E, Hartmann E, Koehler M: Nuclear translocation of hypoxia-inducible factors (HIFs): Involvement of the classical importin β pathway. Biochim Biophys Acta 2008;1783:394-404.
47. Steinhoff A, Pientka FK, Moeckel S, Kettelhake A, Hartmann E, Koehler M, Depping R: Cellular oxygen sensing: Importins and exportins are mediators of intracellular localisation of prolyl-4-hydroxylases PHD1 and PHD2. Biochem Biophys Res Commun 2009;387:705-711.
48. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacterophage T4. Nature 1970;227:680-685.
49. Macara IG: Transport into and out of the nucleus. Microbiol Mol Biol Rev 2001;65:570-594.
50. Rivera MN, Haber DA: Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 2005;5:699-712. (Pubitemid 41486363)
51. Smolen GA, Vassileva MT, Wells J, Matunis MJ, Haber DA: SUMO-1 modification of the Wilms' tumor suppressor WT1. Cancer Res 2004;64:7846-7851. (Pubitemid 39446917)
52. Ye Y, Raychaudhuri B, Gurney A, Campbell CE, Williams BR: Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J 1996;15:5606-5015.
53. Vandromme M, Gauthier-Rouvière C, Lamb N, Fernandez A: Regulation of transcription factor localization: fine-tuning of gene expression. Trends Biochem Sci 1996;21:59-64.
54. Dudnakova T, Spraggon L, Slight J, Hastie N: Actin: a novel interaction partner of WT1 influencing its cell dynamic properties. Oncogene 2010;29:1085-1092.
55. Breeuwer M, Goldfarb DS: Facilitated nuclear transport of histone H1 and other small nucleophilic proteins. Cell 1990;60:999-1008.
56. Fagerlund R, Kinnunen L, Koehler M, Julkunen I, Melén K: NF-βB is transported into the nucleus by importin 3 and importin 4. J Biol Chem 2005;280:15942-15951.
57. Koehler M, Goerlich D, Hartmann E, Franke J: Adenoviral E1A protein nuclear import is preferentially mediated by importin alpha3 in vitro. Virology 2001;289:186-191. (Pubitemid 33140998)
58. Quensel C, Friedrich B, Sommer T, Hartmann E, Koehler M: In vivo analysis of importin alpha proteins reveals cellular proliferation inhibition and substrate specificity. Mol Cell Biol 2004;24:10246-10255. (Pubitemid 39507863)
59. Welch K, Franke J, Koehler M, Macara IG: RanBP3 contains an unusual nuclear localization signal that is imported preferentially by importin-alpha3. Mol Cell Biol 1999;19:8400-8411. (Pubitemid 30414034)
60. Dingwall C, Sharnick SV, Laskey RA: A polypeptide domain that specifies migration of nucleoplasmin into the nucleus. Cell 1982;30:449-458.
61. Kalderon D, Roberts BL, Richardson WD, Smith AE: A short amino acid sequence able to specify nuclear location. Cell 1984;39:499-509. (Pubitemid 15198589)
62. Bruening W, Moffett P, Chia S, Heinrich G, Pelletier J: Identification of nuclear localization signals within the zinc fingers of the WT1 tumor suppressor gene product. FEBS Lett 1996;393:41-47. (Pubitemid 26298225)
63. Englert C, Vidal M, Maheswaran S, Ge Y, Ezzell RM, Isselbacher KJ, Haber DA: Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc Nat Acad Sic USA 1995;92:11960-11964. (Pubitemid 26013990)
64. Cingolani G, Bednenko J, Gillespie MT, Gerade L: Molecular basic for the recognition of a nonclassical nuclearlocalization signal by importin β. Mol Cell 2002;10:1345-1353. (Pubitemid 36050876)
65. Quek HH, Chow VT, Tock EP: The third zinc finger of the WT1 gene is mutated in Wilms' tumour but not in a broad range of other urogenital tumours. Anticancer Res 1993;13:1575-1580. (Pubitemid 23334793)